Table 4.
Conc. | AMD3465, % | CMPD-167, % | AMD + CMPD-167, % | BMS-C, % | T-1249, % | CoR* + BMS-C, % | CoR + T-1249, % | BMS-C + T-1249, % | Quadruple combination, % |
---|---|---|---|---|---|---|---|---|---|
Low† | 0 | 0 | 0 | 29 | 0 | 29 | 14 | 43 | 71 |
High‡ | 29 | 14 | 43 | 86 | 0 | 100 | 100 | 100 | 100 |
Top§ | 71 | 14 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
*CoR, mixture of AMD3465 with CMPD167.
†AMD3465, 5 nM; CMPD-167, 0.1 nM; all others, 1 nM, alone and in combinations.
‡AMD3465, 50 nM; CMPD-167, 1 nM; all others, 10 nM, alone and in combinations.
§AMD3465, 5 μM; CMPD-167, 100 nM; all others, 1 μM, alone and in combinations. At this high concentration of AMD3465, nonspecific effects on R5 virus infection were also seen.